Share
4,509 Posts.
lightbulb Created with Sketch. 4665
clock Created with Sketch. 31/03/25
08:14
Share
Originally posted by jds1988:
↑
TBH many bio techs de/prioritise their works, Another company comes to mind that recently did the same....But I suppose that's the whole point of not being a one trick pony. Her-vaxx completed phase 2 with favourable results, yes it's not going to take-over Herceptin but it didn't fail. Phase 3 simply cost too much, so unless there is a buyer, there is no need/ability to continue.
Expand
I agree SOI is a bit of a drag, but I never hear anyone talk about No. of shareholders. combined . IMU has more shareholders with unmarketable parcels than NEU has total shareholders. https://hotcopper.com.au/threads/imugene-chart-ta-only.5967260/page-36662?post_id=78384865
(20min delay)